It’s High Time For The Cannabis-Related Drug Pipeline

It's High Time For The Cannabis-Related Drug Pipeline

Zynerba Pharmaceuticals, Inc (NASDAQ: ZYNE) gave investors an update on its clinical program this week. Like weeds, specialty pharmaceutical companies have sprung up and engaged in developing commercially viable therapies based on cannabinoids, a primary compound found in cannabis.

In light of the impending results from Zynerba, below is a list of prominent cannabinoid product platforms in the clinical stage.

Zynerba

Zynerba expects top-line results from two trials in August. The STAR-1 trial, exploring its ZYN002 treatment for adult epilepsy, should see

... read more at: https://www.benzinga.com/general/biotech/17/08/9875155/its-high-time-for-the-cannabis-related-drug-pipeline

by

Leave a Reply

Your email address will not be published. Required fields are marked *